Virogenomics BioDevelopment Inc SBIR Phase II Award, April 2020
A SBIR Phase II contract was awarded to Virogenomics BioDevelopment Inc in April, 2020 for $998,210.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.